KRYS
Krystal Biotech, Inc.
Stock
$322.28−3.03 (−0.93%)Close Oct 2, 2026
- Selling, general and administrative, 2025
- $147M
- YoY, 2025
- +29.1%
Selling, general and administrative
Selling, general and administrative by fiscal year
| Period | SG&A | YoY |
|---|---|---|
| 2025 | $147M | +29.1% |
| 2024 | $114M | +15.6% |
| 2023 | $98M | +26.4% |
| 2022 | $78M | — |